Medicure (MCUJF) Share-based Compensation (2009 - 2026)
Medicure's (MCUJF) quarterly Share-based Compensation came in at $2187.6 in Q1 2026, down 91.28% year-on-year from $25089.0 in Q1 2025, and down 91.28% quarter-over-quarter from $25098.0 in Q4 2025.
Medicure (MCUJF) Share-based Compensation (2009 - 2026) Analysis & Trends
Medicure's Share-based Compensation history runs 16 years deep, the most recent figure standing at $2187.6 for Q1 2026.
- On a quarterly basis, Share-based Compensation fell 91.28% year-over-year to $2187.6 in Q1 2026; TTM through Mar 2026 was $74369.2, a 40.64% decrease from a year earlier, with the FY2025 full-year figure at $97338.1, down 32.01% from the prior year.
- Share-based Compensation retreated to $2187.6 in Q1 2026 per MCUJF's latest filing, from $25098.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $61166.3 in Q3 2023 and bottomed at $2187.6 in Q1 2026.
- The 5-year median for Share-based Compensation is $33382.7 (2022), against an average of $33905.8.
- Across the five-year window, Share-based Compensation surged 170.06% in 2023 and slumped 91.28% in 2026, its largest moves.
- Year by year, Share-based Compensation stood at $38337.3 in 2022, then soared by 45.61% to $55824.7 in 2023, then slumped by 33.32% to $37224.2 in 2024, then slumped by 32.58% to $25098.0 in 2025, then slumped by 91.28% to $2187.6 in 2026.
- Per Business Quant, the three latest MCUJF Share-based Compensation figures stand at $2187.6 (Q1 2026), $25098.0 (Q4 2025), and $25432.2 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | 2,187.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,187.62 |
| Mar 31, 2026 | 2,187.62 |
| Dec 31, 2025 | 25,098.02 |
| Dec 31, 2025 | 25,098.02 |
| Sep 30, 2025 | 25,432.23 |
| Sep 30, 2025 | 25,432.23 |
| Jun 30, 2025 | 21,651.37 |
| Jun 30, 2025 | 21,651.37 |
| Mar 31, 2025 | 25,088.99 |
| Mar 31, 2025 | 25,088.99 |
| Dec 31, 2024 | 37,224.16 |
| Dec 31, 2024 | 37,224.16 |
| Sep 30, 2024 | 32,254.35 |
| Sep 30, 2024 | 32,254.35 |
| Jun 30, 2024 | 30,707.90 |
| Jun 30, 2024 | 30,707.90 |
| Mar 31, 2024 | 43,042.57 |
| Mar 31, 2024 | 43,042.57 |
| Dec 31, 2023 | 55,824.70 |
| Dec 31, 2023 | 55,824.70 |